Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • thondeboer
    Member
    • Jan 2009
    • 24

    #1

    Hi from Complete Genomics!

    Hi,

    I'm Thon, the product manager for Bioinformatics for Complete Genomics and I will be following these threads with interest!

    As you may know, we are a complete genome sequencing company that is about to launch our sequencing service for whole human genomes and we are going to make it very affordable....

    I will be here to answer any questions you may have about our company and our data formats....

    For those that are going to AGBT in Florida this week, I would highly recommend you visit our hospitality suite after our talk on Thursday for some exciting news!

    Thon
    Complete Genomics, Inc.
    Thon
    __________________________________
    Thon de Boer, Ph.D.
    Director of Product Management, Software
    Strand Life Sciences
    548 Market Street, Suite 82804
    San Francisco, CA 94104, USA
    [email protected]
    www.strandls.com
    Pioneers in Discovery Research Informatics
    _______________________________________
  • Patrick
    Member
    • Mar 2009
    • 27

    #2
    Some question confuse about the Complete Genome sequencing technique

    1. Can I know more about the technique used by your company for sequencing the human genome?
    2. I confused about the base read of your company provided? Is it 35 bp? 70 bp? or 80 bp? I got saw one website mention that it was 35 bp. Is it correct?
    3. Is it your company more advance and faster in sequencing when comparing to Solexa and 454? As I know, 454 is about 96 MB per day and Solexa is 500 MB per day.

    Thanks a lot for your answer to solve my confusion.
    Hope really can get a $5,000 genome sequencing soon.

    Best regards
    Patrick

    Comment

    • doxologist
      Member
      • Jan 2009
      • 96

      #3
      I second the interest in the specs.

      Comment

      • thondeboer
        Member
        • Jan 2009
        • 24

        #4
        There are some more specifics in some other threads on this board.

        Sequencing technologies without a commercially released platform (Oxford Nanopore, Halcyon Molecular, etc.)


        and

        Sequencing technologies without a commercially released platform (Oxford Nanopore, Halcyon Molecular, etc.)


        You can also get more information from our website. There you can find the API and the Whitepaper on our technology.

        Let me know if you need more information!

        Thon
        Complete Genomics
        Thon
        __________________________________
        Thon de Boer, Ph.D.
        Director of Product Management, Software
        Strand Life Sciences
        548 Market Street, Suite 82804
        San Francisco, CA 94104, USA
        [email protected]
        www.strandls.com
        Pioneers in Discovery Research Informatics
        _______________________________________

        Comment

        • doxologist
          Member
          • Jan 2009
          • 96

          #5
          thanks for the info.

          Comment

          • joa_ds
            Member
            • Dec 2008
            • 52

            #6
            btw, the big boss disappointed me on CHI.

            I was proud i had our sequencing facility up and running with a private 16 core server with 12TB storage and access to a 6k core cluster for the really big tasks.

            And then you guys announce plans for a 60k cluster and 30 PB storage...


            Btw, patrick: http://www.completegenomics.com/tech...alDetails.aspx

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 11:13 AM
            0 responses
            17 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, Yesterday, 10:48 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            36 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            42 views
            0 reactions
            Last Post SEQadmin2  
            Working...